In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Robert Fisher
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Robert Fisher

RESEARCHER INFORMATION
First Name:Robert
Last Name:Fisher
Title:Mr.
Advanced Degrees:MS
Affiliation:UT Southwestern Medical Center (retired)
Department:Psychiatry
Street Address 1:3218 Fairwood Dr
City:Garland
State/Province:TX
Zip/Postal Code:75040
Country/Territory:U.S.A.
Phone:972-414-3314
Email Address: 
Disclosure:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 24 December 2005]
View all comments by Robert Fisher
Clinical Interests:
Depression
Research Focus:
Neuroanatomy/Systems Neuroscience, Clinical trials, Pharmacology, Chemistry/pharmacology, Neuropathology, GABAergic transmission
Work Sector(s):
Medical hospital
Web Sites:
Personal: NA
Professional: NA
Lab: NA
Reasearcher Bio
Currently semi-retired. Was the Research Study Coordinator for CATIE study at UT Southwestern Medical Center-Dallas-MJ Byerley PI. We were second largest CATIE site.
Top Papers
NA
What is your leading hypothesis?
Dopamine hypothesis in general but recent neuroimaging and success w/ other meds indicate changes in GABA and 5HT that may have a significant impact on the "schizophrenic" type depression and related anxiety and OCD traits.
What piece of missing evidence would help prove it?
More polypharmacy studies using some of SSNRI's in combination w/ anti-pschotic meds (eg: aripriprisole)



Research Participants
Collaborators
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright